The Molecular Genetics unit will facilitate the use of state-of-the-art genetic technologies in all of the projects in the Program. The responsibilities of Core D will involve the performance of two separate but related functions: 1) Maintain a Breeding Colony to provide transgenic rats, expressing the mouse Ren-2 gene, for all of the projects in the Program. It is anticipated that the Program will require the production of 700 hemizygous transgenic offspring with a like number of controls each year. This will be accomplished with a 3-stage breeding strategy that will simultaneously produce mRen-2 hemizygotes along with transgene negative littermates to act as controls. The plans for the breeding strategy were originated in conjunction with Dr. Detlev Ganten, a developer of the TGR(mRen-2)27 hypertensive rat strain. Rats will have the transgenic genotype confirmed by with the resources of the Molecular Biology section of the Core. 2) Provide a Molecular Biology Core with the reagents and expertise necessary to facilitate the completion of the molecular biology protocols described in the individual projects. The major activity of this segment of Core D will be to adapt methodologies for the monitoring of gene expression to the specific needs of the projects requiring this level of measurement.
Major aims related to the localization and quantitation of gene products involved in the RAS are part of 5 of the 6 projects. In addition to the set-up and performance of the assays, it is envisioned that the Core function will involve a major degree of consultation, information exchange, and instruction directed to the PI's and technical staff of the involved projects so that the repeated procedures can be undertaken directly by the appropriate investigator's personnel. Available technologies to localize and monitor levels of gene expression will include: in situ hybridization of tissue sections and solution hybridization / nuclease protection assays and PCR-mediated detection of cell-specific mRNA production. These functions are intertwined and the activities will be performed by the same personnel.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL051952-04
Application #
6242322
Study Section
Project Start
1997-04-01
Project End
1998-03-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Dell'Italia, Louis J; Collawn, James F; Ferrario, Carlos M (2018) Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling. Circ Res 122:319-336
Ahmad, Sarfaraz; Ferrario, Carlos M (2018) Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018). Expert Opin Ther Pat 28:755-764
Wang, Hao; Sun, Xuming; Lin, Marina S et al. (2018) G protein-coupled estrogen receptor (GPER) deficiency induces cardiac remodeling through oxidative stress. Transl Res 199:39-51
Ahmad, Sarfaraz; Sun, Xuming; Lin, Marina et al. (2018) Blunting of estrogen modulation of cardiac cellular chymase/RAS activity and function in SHR. J Cell Physiol 233:3330-3342
Li, Tiankai; Zhang, Xiaowei; Cheng, Heng-Jie et al. (2018) Critical role of the chymase/angiotensin-(1-12) axis in modulating cardiomyocyte contractility. Int J Cardiol 264:137-144
Wang, Hao; Sun, Xuming; Chou, Jeff et al. (2017) Inflammatory and mitochondrial gene expression data in GPER-deficient cardiomyocytes from male and female mice. Data Brief 10:465-473
Zhang, Xiaowei; Cheng, Heng-Jie; Zhou, Peng et al. (2017) Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure. Int J Cardiol 236:405-412
Ola, Mohammad Shamsul; Alhomida, Abdullah S; Ferrario, Carlos M et al. (2017) Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-( 1-12) Axis in the Pathogenesis of Diabetic Retinopathy. Curr Med Chem 24:3104-3114
Ferrario, Carlos M; Mullick, Adam E (2017) Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease. Pharmacol Res 125:57-71
Chappell, Mark C; Al Zayadneh, Ebaa M (2017) Angiotensin-(1-7) and the Regulation of Anti-Fibrotic Signaling Pathways. J Cell Signal 2:

Showing the most recent 10 out of 309 publications